Evidence map›Paper›PMID 38683820›Full record

ArticlePLOS global public health2024

Who is missed in a community-based survey: Assessment and implications of biases due to incomplete sampling frame in a community-based serosurvey, Choma and Ndola Districts, Zambia, 2022.

Natalya Kostandova, Simon Mutembo, Christine Prosperi, Francis Dien Mwansa, Chola Nakazwe, Harriet Namukoko, Bertha Nachinga, Gershom Chongwe, Innocent Chilumba, Kalumbu H Matakala and 16 more

Abstract read
In one paragraph

Article in PLOS global public health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors.

Natalya KostandovaDepartment of Epidemiology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, United States of America.ORCID https://orcid.org/0000-0002-6184-531X
Simon MutemboDepartment of International Health, International Vaccine Access Center, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, United States of America.
Christine ProsperiDepartment of International Health, International Vaccine Access Center, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, United States of America.ORCID https://orcid.org/0000-0003-1942-5319
Francis Dien MwansaDepartment of Immunizations, Ministry of Health, Government of the Republic of Zambia, Lusaka, Zambia.
Chola NakazweInformation, Research and Dissemination, Zambia Statistics Agency, Lusaka, Zambia.ORCID https://orcid.org/0000-0002-7922-1222
Harriet NamukokoPopulation and Social Statistics, Zambia Statistics Agency, Lusaka, Zambia.
Bertha NachingaInformation, Research and Dissemination, Zambia Statistics Agency, Lusaka, Zambia.
Gershom ChongweTropical Diseases Research Centre, Ndola, Zambia.ORCID https://orcid.org/0000-0003-3303-308X
Innocent ChilumbaBiomedial Sciences Department, Tropical Diseases Research Centre, Ndola, Zambia.
Kalumbu H MatakalaClinical Research Department, Macha Research Trust, Macha, Zambia.ORCID https://orcid.org/0000-0003-3536-2645
Gloria MusukwaMacha Research Trust, Macha, Zambia.ORCID https://orcid.org/0000-0001-7301-3521
Mutinta HamahuwaClinical Research Laboratory Department, Macha Research Trust, Macha, Zambia.
Webster MufwambiAdministration, Tropical Diseases Research Centre, Ndola, Zambia.
Japhet MatobaMolecular Biology Department, Macha Research Trust, Macha, Zambia.
Kenny SitutuTropical Diseases Research Centre, Ndola, Zambia.
Irene MutaleTropical Diseases Research Centre, Ndola, Zambia.
Alex C KongDepartment of International Health, International Vaccine Access Center, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, United States of America.ORCID https://orcid.org/0009-0002-5771-2757
Edgar SimulunduMacha Research Trust, Macha, Zambia.
Phillimon NdubaniMacha Research Trust, Macha, Zambia.
Alvira Z HasanDepartment of International Health, International Vaccine Access Center, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, United States of America.
Shaun A TrueloveDepartment of Epidemiology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, United States of America.ORCID https://orcid.org/0000-0003-0538-0607
Amy K WinterDepartment of International Health, International Vaccine Access Center, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, United States of America.
Andrea C CarcelenDepartment of International Health, International Vaccine Access Center, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, United States of America.ORCID https://orcid.org/0000-0001-6271-6387
Bryan LauDepartment of Epidemiology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, United States of America.
William J MossDepartment of Epidemiology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, United States of America.
Amy WesolowskiDepartment of Epidemiology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, United States of America.

Funding

Human mobility models to forecast disease dynamics and the effectiveness of public health interventionsR01AI160780 · NIAID · JOHNS HOPKINS UNIVERSITY · PI CUMMINGS, DEREK A, WESOLOWSKI, AMY · 2021 to 2025
$3.3M
Disease Emergence and Elimination: Using Mobility Data to Inform Spatial Disease DynamicsDP2LM013102 · NLM · JOHNS HOPKINS UNIVERSITY · PI WESOLOWSKI, AMY · 2018 to 2018
$2.5M
Research in practice: translating infectious disease epidemiology RIP-TIDET32AI165369 · NIAID · JOHNS HOPKINS UNIVERSITY · PI WILLIAM J MOSS · 2022 to 2026
$1.5M
NIAID NIH HHS R01 AI160780NIAID NIH HHS T32 AI165369NLM NIH HHS DP2 LM013102
6 · The paper itself

Abstract

Community-based serological studies are increasingly relied upon to measure disease burden, identify population immunity gaps, and guide control and elimination strategies; however, there is little understanding of the potential for and impact of sampling biases on outcomes of interest. As part of efforts to quantify measles immunity gaps in Zambia, a community-based serological survey using stratified multi-stage cluster sampling approach was conducted in Ndola and Choma districts in May-June 2022, enrolling 1245 individuals. We carried out a follow-up study among individuals missed from the sampling frame of the serosurvey in July-August 2022, enrolling 672 individuals. We assessed the potential for and impact of biases in the community-based serosurvey by i) estimating differences in characteristics of households and individuals included and excluded (77% vs 23% of households) from the sampling frame of the serosurvey and ii) evaluating the magnitude these differences make on healthcare-seeking behavior, vaccination coverage, and measles seroprevalence. We found that missed households were 20% smaller and 25% less likely to have children. Missed individuals resided in less wealthy households, had different distributions of sex and occupation, and were more likely to seek care at health facilities. Despite these differences, simulating a survey in which missed households were included in the sampling frame resulted in less than a 5% estimated bias in these outcomes. Although community-based studies are upheld as the gold standard study design in assessing immunity gaps and underlying community health characteristics, these findings underscore the fact that sampling biases can impact the results of even well-conducted community-based surveys. Results from these studies should be interpreted in the context of the study methodology and challenges faced during implementation, which include shortcomings in establishing accurate and up-to-date sampling frames. Failure to account for these shortcomings may result in biased estimates and detrimental effects on decision-making.

Identifiers

PMID38683820
PMCPMC11057754

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.